nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—EDNRA—GPCRs, Other—P2RY11—narcolepsy	0.0221	0.0221	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—HCRTR2—narcolepsy	0.018	0.018	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—HCRTR1—narcolepsy	0.018	0.018	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0177	0.0177	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0177	0.0177	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—P2RY11—narcolepsy	0.0173	0.0173	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0161	0.0161	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0161	0.0161	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0155	0.0155	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—HCRT—narcolepsy	0.0147	0.0147	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0146	0.0146	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0132	0.0132	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—PENK—narcolepsy	0.013	0.013	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0128	0.0128	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0128	0.0128	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0127	0.0127	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0127	0.0127	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—P2RY11—narcolepsy	0.0124	0.0124	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0119	0.0119	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0119	0.0119	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—TRH—narcolepsy	0.0112	0.0112	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—TRH—narcolepsy	0.011	0.011	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—HCRT—narcolepsy	0.0106	0.0106	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0104	0.0104	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00999	0.00999	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00993	0.00993	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00993	0.00993	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00976	0.00976	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00959	0.00959	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00944	0.00944	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—PENK—narcolepsy	0.00929	0.00929	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HCRTR1—narcolepsy	0.00905	0.00905	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HCRTR2—narcolepsy	0.00905	0.00905	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—P2RY11—narcolepsy	0.00874	0.00874	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0087	0.0087	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00851	0.00851	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00851	0.00851	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00822	0.00822	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—TAC1—narcolepsy	0.00812	0.00812	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—NPS—narcolepsy	0.00812	0.00812	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00802	0.00802	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—NPS—narcolepsy	0.00802	0.00802	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—TRH—narcolepsy	0.008	0.008	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—TRH—narcolepsy	0.0079	0.0079	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00757	0.00757	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HCRT—narcolepsy	0.00744	0.00744	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0074	0.0074	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00726	0.00726	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00726	0.00726	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00715	0.00715	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00699	0.00699	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—PENK—narcolepsy	0.00663	0.00663	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00649	0.00649	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HCRTR2—narcolepsy	0.00648	0.00648	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HCRTR1—narcolepsy	0.00648	0.00648	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—P2RY11—narcolepsy	0.00626	0.00626	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00623	0.00623	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—HTR2A—narcolepsy	0.00622	0.00622	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—TAC1—narcolepsy	0.00581	0.00581	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—NPS—narcolepsy	0.00581	0.00581	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00574	0.00574	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—NPS—narcolepsy	0.00574	0.00574	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—TRH—narcolepsy	0.00564	0.00564	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00542	0.00542	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00538	0.00538	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00538	0.00538	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HCRT—narcolepsy	0.00532	0.00532	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0053	0.0053	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0052	0.0052	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0052	0.0052	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HCRTR1—narcolepsy	0.00512	0.00512	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HCRTR2—narcolepsy	0.00512	0.00512	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—P2RY11—narcolepsy	0.00494	0.00494	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HRH3—narcolepsy	0.00494	0.00494	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—HTR2A—narcolepsy	0.00488	0.00488	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—PENK—narcolepsy	0.00474	0.00474	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HCRTR2—narcolepsy	0.00465	0.00465	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HCRTR1—narcolepsy	0.00465	0.00465	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00464	0.00464	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—P2RY11—narcolepsy	0.00449	0.00449	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00437	0.00437	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HCRT—narcolepsy	0.0042	0.0042	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—NPS—narcolepsy	0.00409	0.00409	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—TAC1—narcolepsy	0.00409	0.00409	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—TRH—narcolepsy	0.00403	0.00403	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00385	0.00385	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00385	0.00385	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HCRT—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00378	0.00378	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—PENK—narcolepsy	0.00375	0.00375	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HCRTR2—narcolepsy	0.00366	0.00366	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HCRTR1—narcolepsy	0.00366	0.00366	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—P2RY11—narcolepsy	0.00354	0.00354	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HRH3—narcolepsy	0.00354	0.00354	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—HTR2A—narcolepsy	0.0035	0.0035	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PENK—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HCRTR1—narcolepsy	0.00333	0.00333	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HCRTR2—narcolepsy	0.00333	0.00333	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—P2RY11—narcolepsy	0.00321	0.00321	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—TRH—narcolepsy	0.00318	0.00318	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HCRT—narcolepsy	0.00301	0.00301	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—NPS—narcolepsy	0.00293	0.00293	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—TAC1—narcolepsy	0.00293	0.00293	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—TRH—narcolepsy	0.00289	0.00289	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HRH3—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HCRTR1—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HCRTR2—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HCRT—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PENK—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—P2RY11—narcolepsy	0.00265	0.00265	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HRH3—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR2A—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PENK—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—NPS—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—TAC1—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—TRH—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HCRT—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—TAC1—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—NPS—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—TRH—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PENK—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HRH3—narcolepsy	0.002	0.002	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HCRTR1—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HCRTR2—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—P2RY11—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HRH3—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR2A—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TRH—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—TAC1—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—NPS—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HCRT—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—TAC1—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—NPS—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HRH3—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PENK—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR2A—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR2A—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NPS—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TAC1—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TRH—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HRH3—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR2A—narcolepsy	0.000996	0.000996	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000961	0.000961	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HTR2A—narcolepsy	0.000905	0.000905	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TAC1—narcolepsy	0.000888	0.000888	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NPS—narcolepsy	0.000888	0.000888	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000876	0.000876	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR2A—narcolepsy	0.000747	0.000747	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CHKB—narcolepsy	0.00063	0.00063	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CHKB—narcolepsy	0.000574	0.000574	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR2A—narcolepsy	0.000534	0.000534	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000428	0.000428	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CPT1B—narcolepsy	0.00039	0.00039	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CHKB—narcolepsy	0.000379	0.000379	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000257	0.000257	CbGpPWpGaD
